Author | Craig I. Coleman, PharmD


New treatments for obesity and OAB

September 15, 2012

FDA approves Lorcaserin and Mirabegron extended-release tablets.

Pancrelipase DR caps approved for EPI

August 10, 2012

FDA has approved pancrelipase delayed-release capsules to treat exocrine pancreatic insufficiency resulting from cystic fibrosis or other conditions.

FDA approves oral inhibitor for ED

July 15, 2012

FDA approves avanafil and tafluprost

Lucinactant approved for premie RDS

June 15, 2012

FDA approves Lucinactant and Peginesatide